Chemed Corp: Form 10-Q for the period ended Jun 30, 2011
Filed with the SEC on Aug 5, 2011 and accepted by EDGAR at Aug 5, 2011, 15:57 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2011-06-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2011-04-01 to 2011-06-30 | $333.4m | us-gaap:SalesRevenueNet |
| Revenue | 6 months2011-01-01 to 2011-06-30 | $664.3m | us-gaap:SalesRevenueNet |
| Cost of revenue | 3 months2011-04-01 to 2011-06-30 | $239.6m | us-gaap:CostOfRevenue |
| Cost of revenue | 6 months2011-01-01 to 2011-06-30 | $477.1m | us-gaap:CostOfRevenue |
| Selling, general and administrative | 3 months2011-04-01 to 2011-06-30 | $50.4m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 6 months2011-01-01 to 2011-06-30 | $106.1m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2011-04-01 to 2011-06-30 | $35.8m | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months2011-01-01 to 2011-06-30 | $66.4m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2011-04-01 to 2011-06-30 | $3.5m | us-gaap:InterestExpense |
| Interest expense | 6 months2011-01-01 to 2011-06-30 | $6.7m | us-gaap:InterestExpense |
| Income tax | 3 months2011-04-01 to 2011-06-30 | $12.8m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 6 months2011-01-01 to 2011-06-30 | $24.1m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2011-04-01 to 2011-06-30 | $20.3m | us-gaap:NetIncomeLoss |
| Net income | 6 months2011-01-01 to 2011-06-30 | $38.4m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2011-04-01 to 2011-06-30 | $0.94 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 6 months2011-01-01 to 2011-06-30 | $1.78 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2011-04-01 to 2011-06-30 | $0.96 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 6 months2011-01-01 to 2011-06-30 | $1.82 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2011-04-01 to 2011-06-30 | 21,637,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 6 months2011-01-01 to 2011-06-30 | 21,586,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 6 months2011-01-01 to 2011-06-30 | $51.1m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 6 months2011-01-01 to 2011-06-30 | $15.0m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 6 months2011-01-01 to 2011-06-30 | $6.0m | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 6 months2011-01-01 to 2011-06-30 | $25.5m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2011-06-30 | $50.9m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2011-06-30 | $203.6m | us-gaap:AssetsCurrent |
| Total assets | At period end2011-06-30 | $850.6m | us-gaap:Assets |
| Current liabilities | At period end2011-06-30 | $135.3m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2011-06-30 | $361.3m | us-gaap:Liabilities |
| Long-term debt | At period end2011-06-30 | $162.9m | us-gaap:LongTermDebtNoncurrent |
| Shareholders' equity | At period end2011-06-30 | $489.3m | us-gaap:StockholdersEquity |
| Shares outstanding | At period end2011-06-30 | 21,405,258 shares | dei:EntityCommonStockSharesOutstanding |
Source: SEC EDGAR, the filing index for accession 0001157523-11-004778. Last ingested by Listed: Nov 14, 2026, 12:29 ET. Listed shows no prices and gives no investment advice.